After Ozempic patent expiry, Africa’s biggest drugmaker wins Brazil approval and prepares to enter South Africa’s $182 million GLP-1 race with generic semaglutide

Africa’s largest pharmaceutical manufacturer, Aspen Pharmacare is preparing to enter the fast-growing market for semaglutide after securing regulatory approval for its generic injectable product in Brazil and South Africa.